Inhibition of glycogen synthase kinase 3beta activity with lithium prevents and attenuates paclitaxel-induced neuropathic pain

Neuroscience

Volumn 254, Issue , 2013, Pages 301-311

  Gao, M ^a   Yan, X ^a   Weng, H R ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Chemotherapy; EDTA; Glial; GLT 1; Glutamate transporter; GSK3 ; IL 1 ; LiCl; Neurotoxicity; Nociception; SDS

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL GLUTAMATE TRANSPORTER 1; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 1BETA; LITHIUM CHLORIDE; MAMMALIAN TARGET OF RAPAMYCIN; PACLITAXEL; PROTEIN KINASE B; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LITHIUM;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; NEURALGIA; PHYSIOLOGY; POSTERIOR HORN CELL; SPRAGUE DAWLEY RAT;

ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; MALE; NEURALGIA; PACLITAXEL; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84886248360     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.09.033     Document Type: Article

References (68)

1. Avrahami L., Farfara D., Shaham-Kol M., Vassar R., Frenkel D., Eldar-Finkelman H. Inhibition of glycogen synthase kinase-3 ameliorates beta-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies. J Biol Chem 2013, 288:1295-1306.
2. Banafshe H.R., Mesdaghinia A., Arani M.N., Ramezani M.H., Heydari A., Hamidi G.A. Lithium attenuates pain-related behavior in a rat model of neuropathic pain: possible involvement of opioid system. Pharmacol Biochem Behav 2012, 100:425-430.
3. Beurel E., Jope R.S. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. J Neuroinflamm 2009, 6:9.
4. Beurel E., Jope R.S. Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes. Neurosci 2010, 169:1063-1070.
5. Beurel E., Michalek S.M., Jope R.S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 2010, 31:24-31.
6. Bianco M.R., Cirillo G., Petrosino V., Marcello L., Soleti A., Merizzi G., Cavaliere C., Papa M. Neuropathic pain and reactive gliosis are reversed by dialdehydic compound in neuropathic pain rat models. Neurosci Lett 2012, 530:85-90.
7. Boyette-Davis J., Xin W., Zhang H., Dougherty P.M. Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline. Pain 2011, 152:308-313.
8. Burgos E., Gomez-Nicola D., Pascual D., Martin M.I., Nieto-Sampedro M., Goicoechea C. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells. Eur J Pharmacol 2012, 682:62-72.
9. Cata J.P., Weng H.R., Chen J.H., Dougherty P.M. Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neuroscience 2006, 138:329-338.
10. Cata J.P., Weng H.R., Dougherty P.M. Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anes 2006, 72:151-169.
11. Cata J.P., Weng H.R., Dougherty P.M. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res 2008, 1229:100-110.
12. Chalecka-Franaszek E., Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 1999, 96:8745-8750.
13. Chiu C.T., Wang Z., Hunsberger J.G., Chuang D.M. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev 2013, 65:105-142.
14. Danbolt N.C. Glutamate uptake. Prog Neurobiol 2001, 65:1-105.
15. De Sarno P., Axtell R.C., Raman C., Roth K.A., Alessi D.R., Jope R.S. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol 2008, 181:338-345.
16. Dill J., Wang H., Zhou F., Li S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci 2008, 28:8914-8928.
17. Dougherty P.M., Cata J.P., Cordella J.V., Burton A., Weng H.R. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004, 109:132-142.
18. Doyle T., Chen Z., Muscoli C., Bryant L., Esposito E., Cuzzocrea S., Dagostino C., Ryerse J., Rausaria S., Kamadulski A., Neumann W.L., Salvemini D. Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain. J Neurosci 2012, 32:6149-6160.
19. Flatters S.J., Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 2006, 122:245-257.
20. Freland L., Beaulieu J.M. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci 2012, 5:14.
21. Garcia-Tardon N., Gonzalez-Gonzalez I.M., Martinez-Villarreal J., Fernandez-Sanchez E., Gimenez C., Zafra F. Protein kinase C (PKC)-promoted endocytosis of glutamate transporter GLT-1 requires ubiquitin ligase Nedd4-2-dependent ubiquitination but not phosphorylation. J Biol Chem 2012, 287:19177-19187.
22. Ghoshdastidar D., Dutta R.N., Poddar M.K. In vivo distribution of lithium in plasma and brain. Indian J Exp Biol 1989, 27:950-954.
23. Green H.F., Nolan Y.M. GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia. Neurochem Int 2012, 61:666-671.
24. Hara T., Chiba T., Abe K., Makabe A., Ikeno S., Kawakami K., Utsunomiya I., Hama T., Taguchi K. Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion. Pain 2013, 154:882-889.
25. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
26. Huang W.C., Lin Y.S., Wang C.Y., Tsai C.C., Tseng H.C., Chen C.L., Lu P.J., Chen P.S., Qian L., Hong J.S., Lin C.F. Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 2009, 128:e275-e286.
27. Jiang E., Yan X., Weng H.R. Glial glutamate transporter and glutamine synthetase regulate GABAergic synaptic strength in the spinal dorsal horn. J Neurochem 2012, 121:526-536.
28. Jin H.W., Flatters S.J., Xiao W.H., Mulhern H.L., Bennett G.J. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-l-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol 2008, 210:229-237.
29. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008, 28:5189-5194.
30. Kleibeuker W., Gabay E., Kavelaars A., Zijlstra J., Wolf G., Ziv N., Yirmiya R., Shavit Y., Tal M., Heijnen C.J. IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2. Brain Behav Immun 2008, 22:200-208.
31. Ledeboer A., Liu T., Shumilla J.A., Mahoney J.H., Vijay S., Gross M.I., Vargas J.A., Sultzbaugh L., Claypool M.D., Sanftner L.M., Watkins L.R., Johnson K.W. The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biol 2006, 2:279-291.
32. Li L.B., Toan S.V., Zelenaia O., Watson D.J., Wolfe J.H., Rothstein J.D., Robinson M.B. Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J Neurochem 2006, 97:759-771.
33. Liaw W.J., Stephens R.L., Binns B.C., Chu Y., Sepkuty J.P., Johns R.A., Rothstein J.D., Tao Y.X. Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 2005, 115:60-70.
34. Maixner D.W., Weng H.R. The role of glycogen synthase kinase 3beta in neuroinflammation and pain. J Pharmaceutics Pharmacol 2013, 1:001.
35. Martins D.F., Rosa A.O., Gadotti V.M., Mazzardo-Martins L., Nascimento F.P., Egea J., Lopez M.G., Santos A.R. The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice. J Pain 2011, 12:315-322.
36. Mazzardo-Martins L., Martins D.F., Stramosk J., Cidral-Filho F.J., Santos A.R. Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action. Neuroscience 2012, 226:411-420.
37. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009, 10:23-36.
38. Mo M., Erdelyi I., Szigeti-Buck K., Benbow J.H., Ehrlich B.E. Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment. FASEB J 2012, 26:4696-4709.
39. Morrison J.M., Pritchard H.D., Braude M.C., D'Aguanno W. Plasma and brain lithium levels after lithium carbonate and lithium chloride administration by different routes in rats. Proc Soc Exp Biol Med 1971, 137:889-892.
40. Nie H., Weng H.R. Glutamate transporters prevent excessive activation of NMDA receptors and extrasynaptic glutamate spillover in the spinal dorsal horn. J Neurophysiol 2009, 101:2041-2051.
41. Nie H., Weng H.R. Impaired glial glutamate uptake induces extrasynaptic glutamate spillover in the spinal sensory synapses of neuropathic rats. J Neurophysiol 2010, 103:2570-2580.
42. Nie H., Zhang H., Weng H.R. Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic rats. Neuroscience 2010, 170:901-912.
43. Parkitna J.R., Obara I., Wawrzczak-Bargiela A., Makuch W., Przewlocka B., Przewlocki R. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats. J Pharmacol Exp Ther 2006, 319:832-839.
44. Pevida M., Lastra A., Hidalgo A., Baamonde A., Menendez L. Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia. Brain Res Bull 2013, 95C:21-27.
45. Pourmohammadi N., Alimoradi H., Mehr S.E., Hassanzadeh G., Hadian M.R., Sharifzadeh M., Bakhtiarian A., Dehpour A.R. Lithium attenuates peripheral neuropathy induced by paclitaxel in rats. Basic Clin Pharmacol Toxicol 2012, 110:231-237.
46. Ren K., Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol 2008, 21:570-579.
47. Ruiz-Medina J., Baulies A., Bura S.A., Valverde O. Paclitaxel-induced neuropathic pain is age dependent and devolves on glial response. Eur J Pain 2013, 17:75-85.
48. Shimizu T., Shibata M., Wakisaka S., Inoue T., Mashimo T., Yoshiya I. Intrathecal lithium reduces neuropathic pain responses in a rat model of peripheral neuropathy. Pain 2000, 85:59-64.
49. Sommer C., Petrausch S., Lindenlaub T., Toyka K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1999, 270:25-28.
50. Sun X., Sato S., Murayama O., Murayama M., Park J.M., Yamaguchi H., Takashima A. Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100. Neurosci Lett 2002, 321:61-64.
51. Sung B., Lim G., Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 2003, 23:2899-2910.
52. Sung B., Wang S., Zhou B., Lim G., Yang L., Zeng Q., Lim J.A., Wang J.D., Kang J.X., Mao J. Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats. Pain 2007, 131:121-131.
53. Susarla B.T., Robinson M.B. Internalization and degradation of the glutamate transporter GLT-1 in response to phorbol ester. Neurochem Int 2008, 52:709-722.
54. Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 1993, 296(Pt 1):15-19.
55. Tai Y.H., Wang Y.H., Tsai R.Y., Wang J.J., Tao P.L., Liu T.M., Wang Y.C., Wong C.S. Amitriptyline preserves morphine's antinociceptive effect by regulating the glutamate transporter GLAST and GLT-1 trafficking and excitatory amino acids concentration in morphine-tolerant rats. Pain 2007, 129:343-354.
56. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
57. Vadlakonda L., Dash A., Pasupuleti M., Anil Kumar K., Reddanna P. The paradox of Akt-mTOR interactions. Front Oncol 2013, 3:165.
58. Weng H.R., Aravindan N., Cata J.P., Chen J.H., Shaw A.D., Dougherty P.M. Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia. Neurosci Lett 2005, 386:18-22.
59. Weng H.R., Chen J.H., Cata J.P. Inhibition of glutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation. Neuroscience 2006, 138:1351-1360.
60. Weng H.R., Chen J.H., Pan Z.Z., Nie H. Glial glutamate transporter 1 regulates the spatial and temporal coding of glutamatergic synaptic transmission in spinal lamina II neurons. Neuroscience 2007, 149:898-907.
61. Weng H.R., Cordella J.V., Dougherty P.M. Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 2003, 103:131-138.
62. Wolf G., Gabay E., Tal M., Yirmiya R., Shavit Y. Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 2006, 120:315-324.
63. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/Factor A. EMBO J 1990, 9:2431-2438.
64. Yan X., Weng H.R. Endogenous interleukin-1beta in neuropathic rats enhances glutamate release from the primary afferents in the spinal dorsal horn through coupling with presynaptic NMDA receptors. J Biol Chem 2013, 288:30544-30557.
65. Yan X., Jiang E., Gao M., Weng H.R. Endogenous activation of presynaptic NMDA receptors enhances glutamate release from the primary afferents in the spinal dorsal horn in a rat model of neuropathic pain. J Physiol 2013, 591:2001-2019.
66. Yuan Y., Wang J.Y., Yuan F., Xie K.L., Yu Y.H., Wang G.L. Glycogen synthase kinase-3beta contributes to remifentanil-induced postoperative hyperalgesia via regulating N-methyl-d-aspartate receptor trafficking. Anesth Analg 2013, 116:473-481.
67. Yuskaitis C.J., Jope R.S. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal 2009, 21:264-273.
68. Zheng F.Y., Xiao W.H., Bennett G.J. The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience 2011, 176:447-454.